Skip to main content
Biocure Technology Inc. logo

Biocure Technology Inc. — Investor Relations & Filings

Ticker · CURE.X LEI · 529900KSL59IBBDYBU95 CSE Manufacturing
Open in API
Filings indexed 149 across all filing types
Latest filing 2026-04-15 Regulatory Filings
Country CA Canada
Listing CSE CURE.X

About Biocure Technology Inc.

https://biocuretech.com/

Biocure Technology Inc. is a biopharmaceutical company specializing in the development and commercialization of advanced biological medicines. The company's core focus areas include proprietary CAR T-cell therapies designed to treat various cancers, such as leukemia, lung, and breast cancer. Concurrently, Biocure is engaged in the development and commercialization of major biosimilar pharmaceutical products, aiming to improve the accessibility of complex biological treatments. Furthermore, the company pursues novel, highly-efficacious therapies for severe diseases caused by RNA viruses where significant unmet medical needs exist.

Recent filings

Filing Released Lang Actions
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).PDF
Regulatory Filings Classification · 1% confidence The document is Form 13-502F1 filed with the Ontario Securities Commission detailing quarterly market values and participation fee calculations under OSC Rule 13-502 Fees. It is a regulatory compliance filing rather than an annual/quarterly report, earnings release, M&A announcement, etc. It does not announce or present a report, but is itself a regulatory submission for fee payment, making it a general regulatory filing (fallback category).
2026-04-15 English
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).PDF
Regulatory Filings Classification · 1% confidence The document is Form 13-501F1, a standardized compliance filing submitted to the Alberta Securities Commission to calculate participation fees and include management certification. It is not a financial report (10-K, IR) nor an earnings release or corporate announcement. It is a regulatory form, so it falls under the generic “Regulatory Filings” category (RNS).
2026-04-15 English
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).PDF
Regulatory Filings Classification · 1% confidence The document is a completed Form 13-502F1 filed with the Ontario Securities Commission under OSC Rule 13-502 Fees. It contains management certification, quarterly trading data, market value calculations, and fee payment details. This is not an annual report, earnings release, or other financial statement; rather it is a regulatory submission of a fee form to a securities regulator. Therefore, it best fits the fallback “Regulatory Filings” category.
2026-04-15 English
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).PDF
Regulatory Filings Classification · 1% confidence The document is Form 13-501F1 – a participation fee and management certification filing submitted to the Alberta Securities Commission. It is a regulatory form and does not fit any specific category such as annual report, interim report, earnings release, or M&A announcement. Therefore, it falls under the fallback category for general regulatory filings.
2026-04-15 English
52-109FV1 - Certification of annual filings - CEO (E).pdf
Regulatory Filings Classification · 1% confidence The document is a standalone certification form (Form 52-109FV1) filed by the CEO under Canadian National Instrument 52-109, certifying the company’s annual filings. It is not the annual report itself, nor a press release, earnings release, dividend notice or other specific category; instead it is a regulatory compliance filing. It therefore falls under the fallback “Regulatory Filings” category.
2026-04-15 English
52-109FV1 - Certification of annual filings - CFO (E).pdf
Regulatory Filings Classification · 1% confidence The document is a CFO certificate under Canadian NI 52-109 for venture issuers, certifying the accuracy and completeness of the annual filings (AIF, financial statements, MD&A). It is not the Annual Report itself, nor a proxy, dividend notice, or earnings release. It serves as a regulatory form/certificate accompanying the issuer’s annual filings. None of the specific categories (10-K, IR, MDA, etc.) match this certificate. Therefore, it falls under the fallback category of a general regulatory filing (RNS).
2026-04-15 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.